SCHEMBL19631017

SCHEMBL19631017

Cc1cc(C)c(O)c(C(=O)Nc2nc3c(C(F)(F)F)cccc3s2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
KDM4E B2RXH2 4/20 0.51
POLB P06746 2/20 0.51
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46
TMIGD3 P0DMS9 1/20 0.45
ADORA1 P30542 1/20 0.45
RORC P51449 1/20 0.45
USP2 O75604 1/20 0.45
ALOX15 P16050 1/20 0.45
MCL1 Q07820 1/20 0.45
ESR2 Q92731 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612116 0.90 MEN1 (0.51) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL19631014 0.86 ALDH1A1 (0.44) MEN1KMT2AKDM4EPOLBALDH1A1
Monoethanolamine SCHEMBL28921820 0.84 MEN1 (0.46) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL19627237 0.81 KDM4E (0.46) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL17770319 0.79 TMPRSS4 (0.55) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL19631018 0.79 DYRK1A (0.63) MEN1KMT2ANPC1RAB9ADYRK1A
SCHEMBL31237407 0.79 TMPRSS4 (0.55) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL19627232 0.77 KMT2A (0.62) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL19612096 0.76 NPC1 (0.45) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL19612105 0.75 CTSD (0.47) KMT2ANPC1RAB9ACASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017201313-A1 NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER JIN SHENGKAN (US) 2017-11-23 WO disclosed